Our Donor
The Searle Funds at The Chicago Community Trust provide the main financial support to the CBC.
- During CBC Phase 1 (2006-2015) the CBC received funding at the level of $5 million per year, from the Searle Funds at The Chicago Community Trust.
- For CBC Phase 2 (2017-2022) the Searle Funds at The Chicago Community Trust have committed a total of $26 million in support.
- For CBC Phase 3 (2023-2025) the Searle Funds at The Chicago Community Trust have committed a total of $13.5 million in support.
In addition, the following donors are acknowledged for contributing to:
CBC Chicago BioCapital Summit (2024):
- Croke Fairchild Duarte & Beres
- Trammell Crow Company
- CDD Vault
- Power Construction
- ESG Architecture & Design
- Prendio BioProcure
- ISEC
- J.P. Morgan
- Lonza
- Amgen
- Chan Zuckerberg Biohub Chicago
- InteliSpark
- Deloitte
- Xentria
- Cytiva
- Sheer Velocity
- Hollister
- Walder Ventures
- 1bio
- Biocentury
- Portal Innovations
- Banc of California
- Phase Capital
CBC Chicago BioCapital Summit (2023):
CBC annual symposia:
- GenScript Probio (19th Annual CBC Symposium; 2022)
- CBRE (17th Annual CBC Symposium; 2020)
- AbbVie (14th Annual CBC Symposium; 2016)
- AbbVie (13th Annual CBC Symposium; 2015)
- Agilent Technologies (9th Annual CBC Symposium; 2011)
- Baxter Healthcare Corporation (9th Annual CBC Symposium; 2011)
- Chicago Council on Science and Technology (C2ST)
(8th Annual CBC Symposium; 2010) - Invitrogen (4th Annual CBC Symposium; 2006)
GIVE